��������

Mark Kockx is a seasoned medical and scientific leader with extensive experience in pathology and fundamental clinical research. As Chief Medical & Scientific Officer and a board member at CellCarta since April 2001, Mark Kockx also co-founded HistoGeneX, which is now part of CellCarta. Previous roles include serving as Head of the Department of Pathology at ZNA from 1994 to 2011 and managing fundamental clinical research at the Fonds Wetenschappelijk Onderzoek - Vlaanderen. Mark Kockx's academic background includes a combined MD and PhD in Medicine from the University of Antwerp, completed in 1994.